High Intensity Interval Versus Focused Ultrasound on Insulin Resistance in Diabetics With Abdominal Obesity
Launched by BADR UNIVERSITY · Apr 18, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different methods to help manage insulin resistance in women with abdominal obesity and diabetes. Insulin resistance means the body doesn’t respond well to insulin, which can lead to high blood sugar levels. The researchers are comparing high-intensity interval exercise (a type of exercise involving short bursts of intense activity) with focused ultrasound (a treatment that uses sound waves) to see which method is more effective in improving insulin sensitivity.
To participate in this trial, women aged 25 to 35 who have a body mass index (BMI) over 30 and a waist circumference of at least 88 cm may be eligible. Participants will be recruited from the El_shinnawy physical therapy Centre. However, women with certain conditions, like skin diseases on the abdomen or heart problems, will not be allowed to join. If eligible, participants can expect to engage in either the exercise or ultrasound treatment over the course of the study, with the goal of helping manage their insulin resistance and improve their overall health. This trial is not yet recruiting participants, so there will be more information available as it gets underway.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • They will be recruited from El_shinnawy physical therapy Centre.
- • All are suffering from abdominal obesity
- • Their age between 25-35 years old
- • Their body mass index more than 30 kg/m2,
- • Their waist circumference ranged from 88 cm
- • The fat thickness at the treatment area was at least 2.5 cm
- Exclusion Criteria:
- • Females having any skin diseases in the abdomen.
- • Female suffering from any physical or mental disorders.
- • Females suffering from abdominal scars or hernia
- • Females didn´t take any medication that might affect their weight all over the study period.
- • Females complaining from any cardiovascular disorders.
About Badr University
Badr University is a leading educational institution committed to advancing healthcare through innovative research and clinical trials. With a focus on fostering collaboration between academia and industry, the university aims to enhance medical knowledge and improve patient outcomes. By leveraging state-of-the-art facilities and a multidisciplinary team of experts, Badr University conducts rigorous clinical trials that adhere to the highest ethical standards and regulatory requirements. Its dedication to scientific excellence and community well-being positions the university as a key player in the advancement of medical science and public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ahmed M. Elshinnawy, Assistant
Principal Investigator
Horus University
Haitham M. Elmasry, Lecturer
Principal Investigator
MTI University
Shimaa hussien ahmed roshdy, Lecturer
Principal Investigator
Misr University for Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported